Shaikhibrahim Z, Lindstrot A, Ochsenfahrt J, et al. Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines[J]. Int J Mol Med, 2013, 31(1): ？21-25.？ [2]Thompson I M, Ankerst D P, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial[J]. J Natl Cancer Inst, 2006, 98(8): 529-534. [3]Shankar S, Mohapatra B, Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif[J]. Biochem Biophys Res Commun, 1998, 243(2): 561-565. [4]Jagadish N, Rana R, Selvi R, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein[J]. Biochem J, 2005, 389(Pt 1): 73-82. [5]Garg M, Kanojia D, Khosla A, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma[J]. Cancer Res, 2008, 68(20): 8240-8248. [6]Wang Y, Dong Q, Miao Y, et al. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer[J]. Lung Cancer, 2013, 81(2): 266-272. [7]Garg M, Kanojia D, Suri S, et al. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth[J]. Cancer, 2009, 115(24): 5688-5699. [8]Sinha A, Agarwal S, Parashar D, et al. Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy[J]. J Exp Clin Cancer Res, 2013, 32: 69. [9]Garg M, Kanojia D, Suri S, et al. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer[J]. J Clin Endocrinol Metab, 2009, 94(11): 4613-4618. [10]Kanojia D, Garg M, Saini S, et al. Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia[J]. Leuk Res, 2010, 34(7): 858-863. [11]Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer[J]. Clin Cancer Res, 2007, 13(5): 1421-1428. [12]Li H, Peng Y, Niu H, et al. SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation[J]. Tumour Biol, 2014, 35(7): 6949-6954. [13]Kanojia D, Garg M, Saini S, et al. Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma[J]. PLoS One, 2013, 8(12): e81348. [14]Ando K, Uemura K, Kuzuya A, et al. N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease[J]. J Biol Chem, 2011, 286(9): 7619-7628.？ [15]Chen F, Lu Z, Deng J, et al. SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro[J]. Oncol Rep, 2014, 32(6): 2533-2540. [16]Andreeva A V, Kutuzov M A, Voyno-Yasenetskaya T A. Scaffolding proteins in G-protein signaling[J]. J Mol Signal, 2007, 2: 13.
[2]
刁鑫伟,叶明福,谢启超,等.二氢睾酮对前列腺癌LNcap和PC-3细胞株EGFR mRNA表达的影响[J].第三军医大学学报,2005,27(16):1690. [2]王家武,姜庆,樊晓栋.新辅助内分泌联合治疗与单纯根治性手术对前列腺癌预后和疗效的Meta分析[J].第三军医大学学报,2011,33(13):1388. Wang Jiawu,Jiang Qing,Fan Xiaodong.Prognosis and efficacy of new adjuvant combination endocrine therapy versus radical surgery for prostate cancer： a meta-analysis study[J].J Third Mil Med Univ,2011,33(10):1388. [3]胡望平,冯福英,叶桂云,等.血清c-PSA及 C/T在提高前列腺癌诊断特异性中的探讨[J].第三军医大学学报,2007,29(18):1815. HU Wang-Ping,FENG Fu-ying,YE Gui-yun,et al.Serum complexed-PSA and ratio of complexed/total PSA to improve diagnostic specificity on identifying prostate cancer[J].J Third Mil Med Univ,2007,29(10):1815. [4]王惠明,王沂芹,阮志华,等.Prostein31-39特异的、HLA-A*2.1限制性NKT细胞表型及功能初步研究[J].第三军医大学学报,2006,28(16):1652. [5]李云祥,苟欣,何卫阳,等.E2F-3, pRb蛋白在前列腺癌中的表达及其临床意义[J].第三军医大学学报,2006,28(15):1611. [6]陈勇,江军,张尧,等.含rPB-DR启动子和TK基因的重组腺病毒的构建和鉴定[J].第三军医大学学报,2006,28(10):1043. [7]吴开杰,张栋,曾津,等.RNAi沉默Smad4基因表达对人前列腺癌细胞增殖的影响[J].第三军医大学学报,2009,31(13):1250. WU Kai-jie,ZHANG Dong,ZENG Jin,et al.Effects of Smad4 gene silencing by small interfering RNA on the proliferation of prostate cancer cells in vitro[J].J Third Mil Med Univ,2009,31(10):1250. [8]张伟杰,马志俊,陆士新,等.前列腺癌组织中DNMT1的表达与GSTP1、APC甲基化状态的关系及临床意义[J].第三军医大学学报,2011,33(15):1602. Zhang Weijie,Ma Zhijun,Lu Shixin,et al.Correlation of DNMT1 expression with GSTP1 and APC methylation and its clinical significance[J].J Third Mil Med Univ,2011,33(10):1602. [9]刁鑫伟,叶明福,张哉根,等.前列腺癌AR表达与细胞增殖的关系[J].第三军医大学学报,2005,27(17):1799. [10]张尧,江军,王洛夫.前列腺特异性启动子rPB的改造及其载体质粒的构建和活性测定[J].第三军医大学学报,2005,27(10):981.
